Hjem › Prækursor T-celle lymfoblastisk leukæmi-lymfom › Texas › Houston
Prækursor T-celle lymfoblastisk leukæmi-lymfom kliniske forsøg i Houston, TX
8 studier for Prækursor T-celle lymfoblastisk leukæmi-lymfom søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RekruttererFase 2
- MD Anderson Cancer Center, Houston
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
RekruttererFase 2
- MD Anderson Cancer Center, Houston
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
RekruttererFase 1
- MD Anderson Cancer Center, Houston
Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
RekruttererFase 1
- UT MD Anderson, Houston
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
RekruttererFase 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
RekruttererFase 2
- M D Anderson Cancer Center, Houston
A Registry for People With T-cell Lymphoma
RekruttererObservationsstudie
- MD Anderson Cancer Center (Data Collection Only), Houston
Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
RekruttererFase 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Prækursor T-celle lymfoblastisk leukæmi-lymfom forsøg i andre byer
- New York City, NY6 studier
- Columbus, OH5 studier
- Washington, DC4 studier
- Philadelphia, PA4 studier
- Baldwin Park, CA3 studier
- St. Louis, MO3 studier
- Boston, MA3 studier
- Edison, NJ3 studier
- Queens, NY3 studier
- New Rochelle, NY3 studier
- Staten Island, NY3 studier
- East Norwalk, CT3 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.